Gubra posts record H1 results on AbbVie deal, trims CRO 2025 outlook; stock down

All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
Switch languages to read your way
Your stories, stored for later
4,006
209
200
41 minutes ago
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
Switch languages to read your way
Your stories, stored for later
4,006
209
200
41 minutes ago
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more